Stock LIFE PHARMSYNTHEZ
Add to a list
To use this feature you must be a member
Log inSign up

Company Pharmsynthez

Equities

LIFE

RU000A0JR514

Pharmaceuticals

End-of-day quote Moscow Micex - RTS
Other stock markets
 23:00:00 07/07/2022 BST 		5-day change 1st Jan Change
4.505 RUB +10.15% Intraday chart for Pharmsynthez -.--% -.--%
2023 Public Joint-Stock Company "Pharmsynthez" Auditor Raises 'Going Concern' Doubt CI
2023 Public Joint-Stock Company "Pharmsynthez" Reports Earnings Results for the Full Year Ended December 31, 2022 CI

Business Summary

Farmsintez PAO (Farmsintez OJSC) is a Russia-based company, which is engaged in the pharmaceutical sector. The Company focuses on the medical research, development and manufacture of drugs ingredients used in oncology, gynecology, tuberculosis therapy and others. In addition, Farmsintez OAO offers chemical research services, chemical technology development and quality control services. The Company sells its products domestically, as well as abroad, including the Commonwealth of Independence State (CIS) countries. It has two wholly owned subsidiaries located in Moscow and Tallin, Estonia. As of May 21, 2011, the Company’s major shareholder was EphaG AS with a stake of 69.23%. In April 2013, the Company acquired the pharmacies of Guardum Pharmaceuticals in the U.S. state of Florida.

Sales per Business

RUB in Million2020Weight2021Weight Delta
Pharmaceuticals
100.0 %
200 100.0 % 438 100.0 % +118.81%

Sales per region

RUB in Million2020Weight2021Weight Delta
Russia
51.0 %
200 100.0 % 224 51.0 % +11.64%
Ukraine
12.3 %
-- 54 12.3 % -
Latvia
10.8 %
-- 47 10.8 % -
United States
7.3 %
-- 32 7.3 % -
Estonia
6.5 %
-- 28 6.5 % -
Other
6.5 %
-- 28 6.5 % -
Kazakhstan
4.1 %
-- 18 4.1 % -
Azerbaijan
1.4 %
-- 6 1.4 % -
Belarus
0.2 %
-- 1 0.2 % -

Managers

Managers TitleAgeSince
Petr Vladimirovich Kruglyakov CEO
 Chief Executive Officer 46 31/12/12
Alexey Shafranov DFI
 Director of Finance/CFO 45 31/12/04
Dmitriy Nikolayevich Poznyak CTO
 Chief Tech/Sci/R&D Officer - -
Sergey Avtushenko BRD
 Director/Board Member 56 31/12/06
Yuliya Yurievna Yakovleva AUD
 Comptroller/Controller/Auditor 53 -
Vladimir Olegovich Kutyrov SAM
 Sales & Marketing 57 -
Artem Vladimirovich Orlov LAW
 General Counsel 48 31/12/12
Roza Vasilyevna Mikhaylova PRN
 Corporate Officer/Principal - -
Alexandra Vladimirovna Tuchkova PRN
 Corporate Officer/Principal - -

Members of the board

Members of the board TitleAgeSince
Steve Gorelik BRD
 Director/Board Member 45 31/12/06
Dmitry Yuryevich Kolosov BRD
 Director/Board Member 44 31/12/12
Dmitriy Genkin CHM
 Chairman 56 31/12/04
Indrek Kasela BRD
 Director/Board Member 52 31/12/06
Alexey Shafranov DFI
 Director of Finance/CFO 45 31/12/04
Alexey Vinogradov BRD
 Director/Board Member 54 02/08/23
Petr Vladimirovich Kruglyakov CEO
 Chief Executive Officer 46 31/12/12
Artem Vladimirovich Orlov LAW
 General Counsel 48 31/12/12
Efim Prilezhaev BRD
 Director/Board Member - 02/08/23
Ivan Ozhgikhin BRD
 Director/Board Member - 02/08/23

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 301,010,754 286,608,971 ( 95.22 %) 0 95.22 %

Company contact information

Pharmsynthez PJSC

IT Park Business Center 25Zh, Krasnogo Kursanta Street

197110, St. Petersburg

+

http://www.pharmsynthez.com
address Pharmsynthez(LIFE)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per region

Sector Other Pharmaceuticals

1st Jan change Capi.
PHARMSYNTHEZ Stock Pharmsynthez
-.--% 14.93M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+32.09% 694B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+29.39% 593B
JOHNSON & JOHNSON Stock Johnson & Johnson
-1.34% 371B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.34% 331B
ABBVIE INC. Stock AbbVie Inc.
+7.39% 290B
ASTRAZENECA PLC Stock AstraZeneca PLC
+14.25% 239B
ROCHE HOLDING AG Stock Roche Holding AG
-3.03% 209B
NOVARTIS AG Stock Novartis AG
+10.02% 209B
AMGEN INC. Stock Amgen Inc.
+8.49% 169B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. LIFE Stock
  4. Company Pharmsynthez